Member Directory

lenses. Alentic has been able to develop small, light-weight yet robust devices that can capture images at high resolution in many important clinical and industrial analysis applications.

lead product, BreatheAlong, determines the respiratory health of sleep apnea patients and provides personalized breathing support. Using this technology on positive airway pressure (PAP) machines will save patients from strokes and heart attacks and reduce health-care costs.

high-quality frozen plasmas, reagents and integrated test kits used in the assessment of coagulation disorders. From our facility in Dartmouth, we currently serve more than 1,000 labs throughout North America with direct overnight delivery, and work with distribution partners to sell to customers overseas. In conjunction with our laboratory, biotech and pharmaceutical partners, we’re also developing new products to improve patient outcomes by addressing current and future challenges in the diagnosis and therapeutic monitoring of disease.

start-up company, incorporated in 2012, was founded after the discovery of a light-activated antimicrobial technology, used by hyper-successful invasive plant species to defend against microbial infections and thrive all over the world. PDI is commercializing this technology to kill the bacteria that causes dental decay, and destroy dental plaque that leads to many oral hygiene conditions. Beginning with an orthodontic treatment to eliminate White Spot Lesions for brace patients, PDI will revolutionize how each of us maintain healthy attractive teeth.

Founded by orthopaedic surgeons, the novel device design restores shoulder function — increasing mobility and strength, while eliminating chronic pain. Where current treatment options are limited with high failure rates, Reach Orthopaedics aims to become the surgical standard of care.

the environment. The company is committed to leading edge research which strives to improve patient outcomes, protect healthcare professionals and reduce overall healthcare cost

Kehoe and an Interventional Radiologist, Dr. Bob Abraham. The company is driven by the unmet need to develop integrated devices to simplify clinical procedures performed by interventional radiologists. Initially, the company is particularly interested in uterine fibroid embolization (UFE). The founders have developed a novel radiopaque embolic agent that will allow UFE to be performed more efficiently and in a safer manner. ABK Biomedical will focus on bringing this technology to market while fostering development of additional technologies that will be added to ABK’s product pipeline.

mandate is to provide a personalized approach to monitor muscle health for improving quality of life and disease state.

and technologies in the field of brain repair. The goal is to avert, alleviate, and repair damage to the brain and spinal cord, and bring about normal neurological functions to patients suffering from brain disorders. The BRC integrates research expertise in stem cell biology, cognitive neuroscience, molecular neurobiology, pharmacology, imaging, neurophysiology, and animal behaviour. The BRC is also involved in a broad range of disorders including: cognitive disorders, epilepsy, ALS, Parkinson’s, dementia, MS, neurodegeneration, movement disorders, and vision.

animal health. BioMedica offers a comprehensive line of diagnostic and research products, recently strengthened through an acquisition of specialty coagulation products and technologies. In the BioMedica line-up, partners will find high-quality kits, controls, reagents, calibrators, antibodies and substrates that are designed for clinical use in routine and specialty coagulation and are also widely used in research and industry environments. BioMedica products are available for sale directly to laboratories and can also be purchased worldwide through a network of elite distributors. Many products are Health Canada Registered, FDA 510(k) cleared and/or CE marked. In addition to clinical partners, BioMedica also works with industry partners to OEM or customize products that are manufactured to a partner’s custom requested specifications, available in a final packaged format or as bulk intermediary product, ready for further manufacture.

laboratory environment. CLI supports single and multiple sites Phase (1) and (2a) clinical trials. CLI can procure study supplies, assemble clinical kits, print customized specimen collection / storage labels, produce specimen shipping logs, and coordinate / monitor specimen shipping. These clearly identified, pre-labled kits ease the burden for personnel at the clinical sites while minimizing collection related data discrepancy.

lenses. Alentic has been able to develop small, light-weight yet robust devices that can capture images at high resolution in many important clinical and industrial analysis applications.

lead product, BreatheAlong, determines the respiratory health of sleep apnea patients and provides personalized breathing support. Using this technology on positive airway pressure (PAP) machines will save patients from strokes and heart attacks and reduce health-care costs.

high-quality frozen plasmas, reagents and integrated test kits used in the assessment of coagulation disorders. From our facility in Dartmouth, we currently serve more than 1,000 labs throughout North America with direct overnight delivery, and work with distribution partners to sell to customers overseas. In conjunction with our laboratory, biotech and pharmaceutical partners, we’re also developing new products to improve patient outcomes by addressing current and future challenges in the diagnosis and therapeutic monitoring of disease.

start-up company, incorporated in 2012, was founded after the discovery of a light-activated antimicrobial technology, used by hyper-successful invasive plant species to defend against microbial infections and thrive all over the world. PDI is commercializing this technology to kill the bacteria that causes dental decay, and destroy dental plaque that leads to many oral hygiene conditions. Beginning with an orthodontic treatment to eliminate White Spot Lesions for brace patients, PDI will revolutionize how each of us maintain healthy attractive teeth.

Founded by orthopaedic surgeons, the novel device design restores shoulder function — increasing mobility and strength, while eliminating chronic pain. Where current treatment options are limited with high failure rates, Reach Orthopaedics aims to become the surgical standard of care.

the environment. The company is committed to leading edge research which strives to improve patient outcomes, protect healthcare professionals and reduce overall healthcare cost

Kehoe and an Interventional Radiologist, Dr. Bob Abraham. The company is driven by the unmet need to develop integrated devices to simplify clinical procedures performed by interventional radiologists. Initially, the company is particularly interested in uterine fibroid embolization (UFE). The founders have developed a novel radiopaque embolic agent that will allow UFE to be performed more efficiently and in a safer manner. ABK Biomedical will focus on bringing this technology to market while fostering development of additional technologies that will be added to ABK’s product pipeline.

mandate is to provide a personalized approach to monitor muscle health for improving quality of life and disease state.

and technologies in the field of brain repair. The goal is to avert, alleviate, and repair damage to the brain and spinal cord, and bring about normal neurological functions to patients suffering from brain disorders. The BRC integrates research expertise in stem cell biology, cognitive neuroscience, molecular neurobiology, pharmacology, imaging, neurophysiology, and animal behaviour. The BRC is also involved in a broad range of disorders including: cognitive disorders, epilepsy, ALS, Parkinson’s, dementia, MS, neurodegeneration, movement disorders, and vision.

animal health. BioMedica offers a comprehensive line of diagnostic and research products, recently strengthened through an acquisition of specialty coagulation products and technologies. In the BioMedica line-up, partners will find high-quality kits, controls, reagents, calibrators, antibodies and substrates that are designed for clinical use in routine and specialty coagulation and are also widely used in research and industry environments. BioMedica products are available for sale directly to laboratories and can also be purchased worldwide through a network of elite distributors. Many products are Health Canada Registered, FDA 510(k) cleared and/or CE marked. In addition to clinical partners, BioMedica also works with industry partners to OEM or customize products that are manufactured to a partner’s custom requested specifications, available in a final packaged format or as bulk intermediary product, ready for further manufacture.

laboratory environment. CLI supports single and multiple sites Phase (1) and (2a) clinical trials. CLI can procure study supplies, assemble clinical kits, print customized specimen collection / storage labels, produce specimen shipping logs, and coordinate / monitor specimen shipping. These clearly identified, pre-labled kits ease the burden for personnel at the clinical sites while minimizing collection related data discrepancy.